Historical Search
Clear historical searches
Common Searches
试剂
测试
EN
Introduction to Pathogens
Pneumocystis
Pneumocystis spp. is a unique, atypical fungus widely distributed across the globe and classified as an opportunistic pathogen. It colonizes host lung tissue, typically causing asymptomatic, latent infections in healthy individuals. However, in hosts with compromised or deficient immune systems, Pneumocystis can proliferate unchecked, leading to Pneumocystis pneumonia (PCP).
Although Pneumocystis has already captured the interest of the scientific community, for many people, these microorganisms remain a mystery. By gaining a deeper understanding of the characteristics and life cycle of the Pneumocystis genus, we can better prevent and manage the lung infections associated with it. Let’s embark on a journey to explore the fascinating world of this microbe!
Discovery and Naming
From 1909 to 1910, Carlos Chagas and Antonio Carini first discovered the organism in the lungs of guinea pigs and rats, respectively, classifying it initially as a member of the genus *Trypanosoma*. However, with the advancement of modern molecular biology techniques in the late 1980s, Edman and Stringer, through sequence analysis of its ribosomal RNA, demonstrated that *Pneumocystis* belongs to the fungal kingdom. Today, it is firmly recognized as a fungus, as detailed in Table 1. The Third International Workshop on Opportunistic Protist (IWOP-3) approved the temporary use of a three-part nomenclature for *Pneumocystis*. Yet, according to the International Code of Nomenclature for algae, fungi, and plants, only a limited number of *Pneumocystis* species have been formally classified and named at the species level. These include *P. jirovecii*, which infects humans; *P. carinii* and *P. wakefieldiae*, which parasitize rats; *P. murina*, which affects mice; and *P. oryctolagi*, which infects rabbits. For other mammalian hosts where *Pneumocystis* species have been identified, the previously mentioned three-part naming system continues to be used.
Table 1: Taxonomic Hierarchy of Pneumocystis [1]
Form and Life Cycle
The developmental process of Pneumocystis outside the host remains unclear, but the development within the host's lung tissue is well understood. The entire life cycle of Pneumocystis occurs entirely within a single host and consists of three distinct stages: the cyst stage, the trophozoite stage, and the pre-cyst stage. The trophozoite is the reproductive form, characterized by a relatively thin wall and pleomorphic morphology; it measures 2–5 µm in size and exhibits both filopodia and pseudopodia, resembling an amoeba. The pre-cyst stage serves as an intermediate form between the cyst and the trophozoite. In contrast, the cyst is the infectious stage, typically spherical or ovoid with a smooth surface, measuring 4–6 µm in diameter and featuring a thick cyst wall, approximately 100–160 nm in thickness. Inside the cyst wall lies the endocystic body (also known as the sporozoite). Fully mature cysts usually contain eight banana-shaped endocystic bodies. Importantly, the cyst itself represents a key diagnostic morphological feature.
The spores of Pneumocystis are transmitted through the air and enter the lungs, where they colonize the surface of type I alveolar cells. Once mature cysts reach the alveoli, they rupture, releasing trophozoites that rapidly multiply—either through asexual binary fission or via sexual reproduction. In the former case, trophozoites undergo asexual replication by dividing into two identical daughter cells. In the latter, nuclear fusion occurs during conjugation, giving rise to a diploid zygote. This zygote then undergoes meiosis, followed by mitosis, ultimately producing eight nuclei. These nuclei are enclosed within the cyst wall as the cytoplasmic material invaginates inward, forming intracystic bodies. As the bodies mature, they eventually extrude from the cyst, emerging as fully developed trophozoites that tightly adhere to the alveolar epithelium, proliferating vigorously. Meanwhile, the trophozoite cell membrane gradually thickens, marking the transition into the pre-cyst stage, during which sporulation begins: at this point, the nuclei inside the cyst undergo further division, with each nucleus surrounded by a distinct mass of cytoplasm, ultimately forming the characteristic intracystic bodies—as illustrated in Figure 1.
Figure 1: The Life Cycle of Pneumocystis [2]
Epidemiology
Pneumocystis is globally distributed and can infect a wide range of mammals, including humans, primates, mice, rabbits, dogs, pigs, and more. Both infected patients and healthy carriers can serve as sources of infection, with rodents and rabbits playing crucial roles as vectors. It is generally believed that Pneumocystis cysts are transmitted via airborne routes, entering the host's lungs where they attach to the surface of pulmonary epithelial cells, often establishing a latent infection. However, when the host's immune system weakens, the organism can multiply rapidly, leading to active disease.
Clinical symptoms and pathological changes
Pneumocystis infection initially presents as a persistent infection without any obvious symptoms. However, when the body develops immune deficiency or severe immunosuppression, distinct symptoms emerge, highlighting the critical role of memory or effector adaptive immunity in effectively preventing fungal invasion [3]. Clinically, patients may exhibit signs such as fever, lethargy, weight loss, coughing, and difficulty breathing. Upon examination, affected lungs often reveal grayish-white nodular lesions on their surface, along with congestion of the alveolar walls. Squeezing these alveolar walls typically releases abundant Pneumocystis trophozoites and cysts—characteristic exudates associated with the infection.
Detection Method
Laboratory diagnostic methods include pathogen detection, immunological testing, and molecular biology-based pathogen analysis. Common pathogen detection methods are listed in Table 2.
Table 2: Pathogen Detection Methods
Immunological assays include ELISA and Western blot for antibody detection, though these methods cannot determine whether the antibodies were produced during an active infection. On the other hand, immunofluorescence and immunohistochemistry techniques are used to detect antigens. In clinical medicine, the EORTC/MSGERC guidelines specify that PCR is the gold-standard diagnostic method for PCP. Meanwhile, several qPCR assay kits have received CE certification and are already in use across Europe, enabling differentiation between colonization and infection by Pneumocystis species within the host organism. Notably, there have been relatively few recent reports on the development of serological testing methods for experimental animals; instead, the discovery and identification of novel Pneumocystis species have largely relied on PCR-based approaches. Looking ahead, future research may increasingly focus on advancing PCR-based diagnostic tools.
Pneumocystis is a microorganism that colonizes the respiratory tracts of laboratory mice and rats, becoming pathogenic under conditions of induced or intrinsic immune deficiency. Infected mice and rats may develop severe Pneumocystis pneumonia after immunosuppression, making them unsuitable for most experimental studies [4]. Therefore, it is essential to test experimental rodents for Pneumocystis prior to conducting experiments, ensuring that interference is ruled out.
On December 29, 2022, the National Standardization Administration Committee and the State Administration for Market Regulation jointly released GB14922-2022, "Laboratory Animals—Microorganisms and Parasites: Classification and Monitoring," revising the classification of *Pneumocystis carinii* in the standard to the bacterial genus *Pneumocystis*. This change highlights the growing recognition of the significance of *Pneumocystis* in laboratory animals, making it one of the essential testing items for experimental rats and mice.
The experimental animal detection method specified in the previous version of the national standard GB/T 18448.4-2001, "Method for Detection of Pneumocystis carinii in Laboratory Animals," was the Giemsa staining technique. Currently, however, the standard detection method has not yet been updated. Therefore, there is an urgent need for scientifically sound documents to guide and properly refine the exploration and development of standardized protocols for detecting Pneumocystis in laboratory animals. Only with the support of rigorous scientific documentation can accurate detection of Pneumocystis in experimental animals be carried out effectively, providing a reliable foundation for experimental design and interpretation of results.
References
[1] Vera C, Rueda ZV. Transmission and Colonization of Pneumocystis jirovecii. J Fungi (Basel), 2021, 7(11).
[2] Cushion MT, Stringer JR. Stealth and opportunism: alternative lifestyles of species in the fungal genus Pneumocystis. Annual Review of Microbiology, 2010, 64: 431-452.
[3] Ma L, Cissé OH, Kovacs JA. A Molecular Window into the Biology and Epidemiology of Pneumocystis spp. Clinical Microbiology Reviews, 2018, 31(3).
[4] Connole MD, Yamaguchi H, Elad D, Hasegawa A, Segal E, Torres-Rodriguez JM. Natural pathogens of laboratory animals and their effects on research. Medical Mycology, 2000, 38 Suppl 1: 59-65.
Table of Contents
Contact Information
Xishan Mobile Website
Xishan Official WeChat